Ryan & Maniskas, LLP Announces Investigation of Physicians Formula Holdings Inc.
August 16 2012 - 10:43AM
Business Wire
Ryan & Maniskas, LLP (www.rmclasslaw.com/cases/face) is
investigating potential claims against the board of directors of
Physicians Formula Holdings Inc. (“Physicians Formula” or the
“Company”) (NASDAQ: FACE) concerning possible breaches of fiduciary
duty and other violations of law related to the Company’s efforts
to sell Physicians Formula to affiliates of Swander Pace Capital in
a transaction valued at approximately $65 million.
Our investigation concerns possible breaches of fiduciary duty
and other violations of law related to the approval of the
transaction by the Company’s board of directors; in particular,
whether the Company undertook a fair process to obtain fair
consideration for all shareholders of Physicians Formula. For more
information regarding our investigation, please contact Ryan &
Maniskas, LLP (Richard A. Maniskas, Esquire) toll-free at (877)
316-3218 or by email at rmaniskas@rmclasslaw.com or visit:
www.rmclasslaw.com/cases/face.
Under the terms of the transaction, Physicians Formula
shareholders will receive $4.25 per share of Physicians Formula
stock they own.
If you own shares of Physicians Formula and would like to learn
more about these claims or if you wish to discuss these matters and
have any questions concerning this announcement or your rights,
contact Richard A. Maniskas, Esquire toll-free at (877) 316-3218 or
to sign up online, visit: www.rmclasslaw.com/cases/face. You may
also email Mr. Maniskas at rmaniskas@rmclasslaw.com. For more
information about class action cases in general, please visit our
website: www.rmclasslaw.com.
Ryan & Maniskas, LLP is a national shareholder litigation
firm. Ryan & Maniskas, LLP is devoted to protecting the
interests of individual and institutional investors in shareholder
actions in state and federal courts nationwide.
Physicians Formula Holdings, Inc. (MM) (NASDAQ:FACE)
Historical Stock Chart
From Mar 2024 to Apr 2024
Physicians Formula Holdings, Inc. (MM) (NASDAQ:FACE)
Historical Stock Chart
From Apr 2023 to Apr 2024
